概括
癌症患者在化疗引起的恶心后对冰淋产生了味道厌恶. 这表明,癌症治疗的症状可以通过改变儿童的食物偏好来减少食欲.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 行为科学 行为科学
背景情况:
- 癌症患者在治疗期间经常经历食欲丧失.
- 化疗可以引起胃肠道毒性,包括恶心和吐.
- 食物厌恶是减少口服摄入量的潜在因素.
研究的目的:
- 为了研究儿童癌症患者的味觉厌恶的发展.
- 为了确定化疗引起的胃肠道毒性是否会影响食物偏好.
- 探索味道厌恶和食欲丧失在这个群体之间的联系.
主要方法:
- 在化疗前,患有瘤疾病的儿科患者被提供了一种新的冰淋口味.
- 食品偏好是通过观察冰淋的后续选择来评估的.
- 经历胃肠道毒性的患者与对照人群进行了比较.
主要成果:
- 与对照组相比,经历了胃肠道毒性的患者不太可能再次选择冰淋.
- 这表明他对冰淋的味道有一种学会的厌恶.
- 这些发现表明有条件的味道厌恶.
结论:
- 化疗诱导的症状可能导致癌症儿童发展味觉厌恶.
- 学习的味觉厌恶可能会显著导致癌症患者观察到的食欲丧失.
- 了解这些厌恶对于癌症治疗期间的营养支持至关重要.
相关概念视频
Taste Buds and Receptors
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
Conditioned Taste Aversion
Conditioned taste aversion, also known as sauce béarnaise syndrome, is a phenomenon in which an individual develops an aversion to a certain food taste following a negative experience, typically illness. This form of aversion is a type of classical conditioning in which the taste of the food (conditioned stimulus, CS) is associated with the experience of illness (unconditioned stimulus, UCS).
A notable characteristic of conditioned taste aversion is that it often requires only a single exposure...
A notable characteristic of conditioned taste aversion is that it often requires only a single exposure...


